Lamictal in Colombia: prescription, pharmacy and pricing
Lamictal (Lamotrigine) is available in Colombia under the regulatory framework of Invima (National Food and Drug Surveillance Institute). This page summarises how the medication is prescribed and dispensed locally, what insurance or the public system cover, and which options exist for legally and safely accessing Lamictal 25mg, 50mg, 100mg, 200mg.
- Regulator
- Invima (National Food and Drug Surveillance Institute)
- Currency
- COP
- Active ingredients
- Lamotrigine
- Available dosages
- 25mg, 50mg, 100mg, 200mg
Prescription status in Colombia
Colombia formally requires prescriptions for Rx medications, but enforcement varies — many medicines that would be Rx in the US or EU are dispensed without prescription at smaller pharmacies. Controlled substances follow a stricter regimen with mandatory documentation under Resolution 1478. Lamictal contains the active ingredient Lamotrigine, in the Neurological Medications class, and its classification in Colombia follows the standard rules of Invima (National Food and Drug Surveillance Institute).
Pharmacy dispensing
Colombian pharmacies (droguerías) include large chains (Cruz Verde, Drogas La Rebaja, Olímpica) and many independents. Pharmacist counselling varies by chain; chain branches typically provide more structured service than independent neighbourhood droguerías. The pharmacist is the most reliable local source of information on stock, authorised substitutions (generic vs brand) and specific precautions for Lamictal at the available strengths (25mg, 50mg, 100mg, 200mg).
Online and tele-prescribing access
Online medicine sale in Colombia operates through chain droguería platforms; Invima oversight requires identification of the dispensing pharmacist. Informal online sale of Rx medications exists outside official channels but is unregulated and risk-prone. Buying Lamictal from unauthorised sellers or without local verification exposes the user to counterfeit medication and unmonitored use of Lamotrigine.
When Lamictal is prescribed
Lamictal is approved in adults and children aged 2 years and older as adjunctive or monotherapy for partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome.
Pricing and availability in COP
Retail pricing in Colombia depends on the strength (25mg, 50mg, 100mg, 200mg), whether the original brand or an authorised generic is dispensed, and insurance or public-system coverage. The difference between brand and generic is usually the most meaningful economic lever for ongoing use. Comparing prices at two or more locally authorised pharmacies before first refill is recommended.
Frequently asked questions
Do I need a prescription for Lamictal in Colombia? ▾
Colombia formally requires prescriptions for Rx medications, but enforcement varies — many medicines that would be Rx in the US or EU are dispensed without prescription at smaller pharmacies. Controlled substances follow a stricter regimen with mandatory documentation under Resolution 1478. In practice, Lamictal follows the status of its active ingredient Lamotrigine in the regulatory system of Invima (National Food and Drug Surveillance Institute).
Is generic Lamictal available in Colombia? ▾
Authorised generics of Lamotrigine are typically available in Colombia at a lower cost than branded Lamictal, with bioequivalence required by Invima (National Food and Drug Surveillance Institute). Substitution is handled by the pharmacist under local equivalence rules.
How much does Lamictal cost in COP? ▾
Prices in COP vary by pharmacy and by strength (25mg, 50mg, 100mg, 200mg). Authorised generics of Lamotrigine are usually substantially cheaper than the brand and are the typical economic reference point for ongoing use in Colombia.
Lamictal in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- CanadaHealth Canada
- South KoreaMFDS (Ministry of Food and Drug Safety)
- JapanPMDA (Pharmaceuticals and Medical Devices Agency)
- AustriaBASG (Federal Office for Safety in Health Care)
- SwitzerlandSwissmedic (Swiss Agency for Therapeutic Products)
- AustraliaTGA (Therapeutic Goods Administration)
- ChileISP (Instituto de Salud Pública de Chile, Public Health Institute)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.